Example of Indian Journal of Gynecologic Oncology format
Recent searches

Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format Example of Indian Journal of Gynecologic Oncology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Indian Journal of Gynecologic Oncology — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Obstetrics and Gynecology #151 of 176 down down by None rank
Oncology #311 of 340 down down by None rank
journal-quality-icon Journal quality:
Low
calendar-icon Last 4 years overview: 362 Published Papers | 60 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 12/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Dove Medical Press

Quality:  
High
CiteRatio: 4.1
SJR: 1.136
SNIP: 1.899
open access Open Access

Springer

Quality:  
High
CiteRatio: 4.8
SJR: 1.154
SNIP: 1.191
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 7.4
SJR: 2.105
SNIP: 1.759
open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 4.2
SJR: 0.747
SNIP: 1.109

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.2

100% from 2019

CiteRatio for Indian Journal of Gynecologic Oncology from 2016 - 2020
Year Value
2020 0.2
2019 0.1
graph view Graph view
table view Table view

0.117

2% from 2019

SJR for Indian Journal of Gynecologic Oncology from 2019 - 2020
Year Value
2020 0.117
2019 0.115
graph view Graph view
table view Table view

0.091

28% from 2019

SNIP for Indian Journal of Gynecologic Oncology from 2019 - 2020
Year Value
2020 0.091
2019 0.071
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 100% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 2% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 28% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Indian Journal of Gynecologic Oncology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Indian Journal of Gynecologic Oncology

Approved by publishing and review experts on SciSpace, this template is built as per for Indian Journal of Gynecologic Oncology formatting guidelines as mentioned in Springer author instructions. The current version was created on and has been used by 253 authors to write and format their manuscripts to this journal.

i
Last updated on
12 Jul 2020
i
ISSN
2363-8397
i
Open Access
Hybrid
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

Journal Article DOI: 10.1007/s40944-022-00694-1
Descriptive Epidemiology of Ovarian Cancers in India: A Report from National Cancer Registry Programme

Topics:

Medicine (84%)84% related to the paper, Ovarian cancer (73%)73% related to the paper, Cancer registry (64%)64% related to the paper, Surgical oncology (63%)63% related to the paper, Epidemiology (58%)58% related to the paper
19 Citations
open accessOpen access Journal Article DOI: 10.1007/S40944-020-00395-7
The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care
Neerja Bhatla1, Seema Singhal1

Abstract:

The impact of the COVID-19 pandemic on world healthcare system and economy is unprecedented. Currently routine surgical procedures are at a halt globally, but whether one can delay cancer procedures remains an ethical issue, and still there is no clarity on how women with gynaecological cancers should be managed in these crit... The impact of the COVID-19 pandemic on world healthcare system and economy is unprecedented. Currently routine surgical procedures are at a halt globally, but whether one can delay cancer procedures remains an ethical issue, and still there is no clarity on how women with gynaecological cancers should be managed in these critical times. Currently available literature on impact of COVID-19 on cancer was reviewed with special reference to its applicability to the Indian context. Cancer cases are more susceptible for COVID-19 infection and rapid deterioration if they get infected. A tumour board should plan their management with a “do no harm” approach as the guiding principle. Teleconsultation may be used to advise patients for therapy and symptom control measures, as well as to advise new patients regarding diagnostic tests. Surgical decision making may be stratified into three categories: patients with low (not life threatening) or intermediate (potential for future morbidity or mortality) acuity may be delayed; those with high acuity may be taken up for planned therapy after explaining the risks. Assessment of the severity of disease, comorbid conditions, and logistic challenges, along with COVID census in their area are important variables for informed and individualized decision making. Safety of healthcare personnel needs to be ensured at the same time. Currently available evidence is limited by small sample size, and full impact of this pandemic on cancer is yet to be seen. However, cancer care needs to be individualized taking all variables into consideration. read more read less
View PDF
19 Citations
Journal Article DOI: 10.1007/S40944-020-00389-5
Clinical Efficacy and Side Effects of IORT as Tumor Bed Boost During Breast-Conserving Surgery in Breast Cancer Patients Following Neoadjuvant Chemotherapy

Abstract:

The efficacy of intraoperative radiotherapy (IORT) as boost dose following neoadjuvant chemotherapy (NACT) is not clearly established yet. This trial evaluated the outcome and complications of IORT boost dose after NACT in patients with breast cancer. This study was a single-arm phase II clinical trial conducted at tertiary r... The efficacy of intraoperative radiotherapy (IORT) as boost dose following neoadjuvant chemotherapy (NACT) is not clearly established yet. This trial evaluated the outcome and complications of IORT boost dose after NACT in patients with breast cancer. This study was a single-arm phase II clinical trial conducted at tertiary referral centers including Omid and Imam Reza Educational Hospitals and Pasteur Private Hospital, Mashhad, Iran. Twenty-four women with breast cancer underwent breast-preservation surgery following the neoadjuvant chemotherapy were enrolled. During BCS, a 20 Gy dose was prescribed to the tumor bed using intrabeam system Zeiss followed by 50 Gy/2 Gy whole breast radiotherapy. Patients were followed for complications of treatment and disease recurrence at 2 years. Toxicity criteria of the RTOG revealed there was only one case of acute toxicity grade 4 as necrosis. During the follow up, two cases of grade III fibrosis were observed. With a median follow up of 29.5 months, one patient died due to cancer with the median survival time of 23.93 months and the 2-year survival rate of 95.5 ± 4.4%. Moreover, one localized relapses in the breast, one recurrent in axillary region and distant metastases, and two distant metastases were diagnosed. The mean free survival was 23.23 months, and the 2-year free survival rate was 87.1%. The results of this study showed that in the short-term follow up, IORT results in terms of local control, side effects and cosmetic outcome after neoadjuvant chemotherapy in breast cancer patients are acceptable. read more read less

Topics:

Breast cancer (62%)62% related to the paper, Survival rate (58%)58% related to the paper, Breast-conserving surgery (57%)57% related to the paper, Median follow-up (55%)55% related to the paper, Cancer (53%)53% related to the paper
15 Citations
open accessOpen access Journal Article DOI: 10.1007/S40944-020-00421-8
Impact of COVID-19 Pandemic on Gynecological Oncology Care: Glimpse into Association of Gynecological Oncologists of India (AGOI) Perspective

Abstract:

The notorious COVID 19 pandemic has caused rapid and drastic changes in cancer care worldwide in 2020. This online survey aims to assess the extent to which the pandemic has affected cancer care in gynecological oncology amongst members of the Association of Gynecological Oncologists of India (AGOI), a registered professional... The notorious COVID 19 pandemic has caused rapid and drastic changes in cancer care worldwide in 2020. This online survey aims to assess the extent to which the pandemic has affected cancer care in gynecological oncology amongst members of the Association of Gynecological Oncologists of India (AGOI), a registered professional society founded in 1991. We developed and administered a cross-sectional, flash survey to members of AGOI in the first week of April 2020. Data were analyzed using Microsoft Office Excel 2016. Results were expressed as percentages of total responses excluding blank or unattended response. Overall theme-specific responses were described as a spectrum of findings, and related inferences were drawn. Among approached practitioners, 90 responded to the survey, more than 80% were practicing consultants, and more than 50% from academic institutions. The results of the study showed that the ongoing pandemic had severely affected gynecological oncology practice and care amongst all respondents. There were modifications in diagnostic pathways, interventions, and follow-ups across all organ sites. There was a near-unanimous opinion on the use of general safety measures to combat the virus and to use complete PPEs in a high-risk situation. There were mixed responses to alternative educational activities, especially using electronic technology and distant learning methods. There was optimism among respondents with regards to the current situation normalizing in 3–6 months. This study documents the pandemic affected scenario of gynecological cancer care and perceptions of Gynecological Oncologists in India. A significant effect on all aspects of cancer care was observed. Technological learning methods, both for patient care and educational activities, were being adopted by many respondents. read more read less
View PDF
11 Citations
Journal Article DOI: 10.1007/S40944-016-0057-1
Noninvasive and Low-Cost Technique for Early Detection of Clinically Relevant Breast Lesions Using a Handheld Point-of-Care Medical Device (iBreastExam): Prospective Three-Arm Triple-Blinded Comparative Study
S. P. Somashekhar1, Ratna Vijay1, Rupa Ananthasivan1, Govindarajan Prasanna1

Abstract:

With limited access to mechanisms of early detection, the vast majority of breast cancer cases present at late stages in developing countries. To determine the clinical efficacy of a handheld point-of-care medical device that could potentially assist allied healthcare workers to perform standardized Clinical Breast Examinatio... With limited access to mechanisms of early detection, the vast majority of breast cancer cases present at late stages in developing countries. To determine the clinical efficacy of a handheld point-of-care medical device that could potentially assist allied healthcare workers to perform standardized Clinical Breast Examination in low-resource settings. Nine hundred and eighty-nine healthy women visiting Manipal Hospital, Bangalore, for annual health check were recruited for bilateral breast examinations. Additionally, 20 women attending the hospital with breast-related symptoms were also recruited as part of the opportunistic screening program. Each woman was examined by three independent methods, each blinded to the other two: iBreastExam (iBE), Clinical Breast Examination (CBE) by an expert clinician and Breast Imaging (mammography or breast ultrasound). Sensitivity, Specificity, PPV, NPV for iBE and CBE were derived with Breast Imaging tests used as reference standard. Out of 916 enrolled participants, 93 were confirmed by imaging to have at least one breast lesion. Clinical Breast Examination in comparison with imaging detected breast lesions with Sn = 65 %, Sp = 94 %, PPV = 52 %, NPV = 96 %, and iBreastExam reported Sn = 84 %, Sp = 94 %, PPV = 60 % and NPV = 98 %. In women below age 40 (314 participants), iBE detected breast lesions with Sn = 85 %, Sp = 93 %. All malignant lesions were identified by iBE, while one non-palpable malignant lesion was missed by clinician CBE. The point-of-care Breast Imaging device (iBreastExam) performed with significantly better sensitivity, by 19 %, than CBE to detect breast lesions while reporting high specificity (94 %) and NPV (98 %). In younger women population under the age of 40 years, where the prevalence of dense breast is high, iBreastExam demonstrated high-performance characteristics. iBreastExam detected all malignant lesions in this study, while the clinician’s CBE missed to detect a non-palpable malignant lesion. iBreastExam can be a promising tool to provide clinically effective and standardized breast examinations in low-resource settings to detect breast lesions at early stages. The device can also be an effective screening tool for younger women with dense breasts. read more read less

Topics:

Breast imaging (64%)64% related to the paper, Breast ultrasound (63%)63% related to the paper, Breast cancer (62%)62% related to the paper, Breast cancer screening (59%)59% related to the paper, Mammography (54%)54% related to the paper
11 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Indian Journal of Gynecologic Oncology.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Indian Journal of Gynecologic Oncology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Indian Journal of Gynecologic Oncology guidelines and auto format it.

2. Do you follow the Indian Journal of Gynecologic Oncology guidelines?

Yes, the template is compliant with the Indian Journal of Gynecologic Oncology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Indian Journal of Gynecologic Oncology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Indian Journal of Gynecologic Oncology citation style.

4. Can I use the Indian Journal of Gynecologic Oncology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Indian Journal of Gynecologic Oncology.

5. Can I use a manuscript in Indian Journal of Gynecologic Oncology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Indian Journal of Gynecologic Oncology that you can download at the end.

6. How long does it usually take you to format my papers in Indian Journal of Gynecologic Oncology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Indian Journal of Gynecologic Oncology.

7. Where can I find the template for the Indian Journal of Gynecologic Oncology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Indian Journal of Gynecologic Oncology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Indian Journal of Gynecologic Oncology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Indian Journal of Gynecologic Oncology an online tool or is there a desktop version?

SciSpace's Indian Journal of Gynecologic Oncology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Indian Journal of Gynecologic Oncology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Indian Journal of Gynecologic Oncology?”

11. What is the output that I would get after using Indian Journal of Gynecologic Oncology?

After writing your paper autoformatting in Indian Journal of Gynecologic Oncology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Indian Journal of Gynecologic Oncology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Indian Journal of Gynecologic Oncology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Indian Journal of Gynecologic Oncology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Indian Journal of Gynecologic Oncology?

The 5 most common citation types in order of usage for Indian Journal of Gynecologic Oncology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Indian Journal of Gynecologic Oncology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Indian Journal of Gynecologic Oncology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Indian Journal of Gynecologic Oncology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Indian Journal of Gynecologic Oncology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Indian Journal of Gynecologic Oncology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template